Promising results for hepatitis vaccine "for" New to enhance the health of health care workers

Mark
Written By Mark

A new study compared the effectiveness of the Heplisav-B vaccine, which is a new vaccine for hepatitis B, with traditional “B” hepatitis B vaccines.

The study showed that a one -enhanced dose of the Hebisaf B vaccine is probably sufficient for most healthy health youths, who are healthy and have previously received a full vaccine chain, simplifying the vaccination program and ensuring a protection against the virus.

The study was conducted by researchers from the Department of Family Medicine, at the University of the Unified Services, Maryland State, and published its results in the Annals of Family Medicine Journal of March 24, and was written by the Yurrick Alert website.

In recent years, the development of vaccines has witnessed remarkable progress, especially in the fight against viral infection, such as hepatitis B. Health care workers, who are routinely exposed to blood and body fluids than patients while carrying out their professional duties more likely to risk infection with hepatitis B infection, requires their vaccination to ensure their protection.

Hepatitis B B.

Hepatitis B is a viral infection that attacks the liver and can cause severe and chronic diseases.

advertisement

The virus is usually transmitted from mother to child during birth, and in early childhood, as well as through body fluids, insecure injections, or exposure to sharp tools.

No symptoms appear on most of the newly patients with hepatitis B. While some people suffer from severe symptoms that last for several weeks, including yellowing of the skin and eyes (jaundice), dark urine, feeling of severe fatigue, nausea, vomiting, and abdominal pain. In severe cases, acute hepatitis may lead to liver failure, which may lead to death.

Although most patients recover from acute disease, some of those with chronic hepatitis B may develop advanced liver diseases and complications such as liver fibrosis and first hepatic cell cancer. These diseases may be fatal. Hepatitis B infection can be prevented through safe, available and effective vaccines.

Hepatitis vaccines “B”

The hepatitis B vaccine is used to prevent infection with the hepatitis B virus. The vaccine stimulates the body’s autoimmune to produce antibodies against the disease.

The vaccine is only available through a doctor or any accredited healthcare profession. The vaccine provides 100% protection against the virus.

Traditional hepatitis B vaccines require 3 doses over 6 months. While the Hibesaf B vaccine is given on two doses.